Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Wilson

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Pediatric Research|November 3, 2025
Co-design and evaluation of a regional and rural translation bronchiolitis platform: study protocolLouise Shaw, Catherine Wilson, Meredith Borland, et al.
Plos Genetics|April 13, 2011
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafishAdriana Rodríguez-Marí, Catherine Wilson, Tom A Titus, et al.
The Medical Journal of Australia|August 14, 2021
The characteristics of SARS-CoV-2-positive children who presented to Australian hospitals during 2020: a PREDICT network studyLaila F Ibrahim, Doris Tham, Vimuthi Chong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2022
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis reportPriya S Kishnani, David Kronn, Anaïs Brassier, et al.
Journal of Neuromuscular Diseases|October 10, 2022
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant CohortTina Duong, Priya S Kishnani, Kristina An Haack, et al.
Current Biology : CB|December 4, 2020
The Developmental and Genetic Architecture of the Sexually Selected Male Ornament of SwordtailsManfred Schartl, Susanne Kneitz, Jenny Ormanns, et al.
BMJ Open|December 23, 2025
Organ donation for research purposes: a qualitative focus group study on the views of donor families, transplant recipients and heart failure patients in the UKJohn Onsy Louca, Nicole Asemota, Johanna Thren, et al.
The Medical Journal of Australia|April 22, 2023
The characteristics of SARS-CoV-2-positive children in Australian hospitals: a PREDICT network studyLaila Ibrahim, Catherine Wilson, Doris Tham, et al.
The Journal of Pediatrics|May 31, 2025
The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase AlfaDavid Kronn, James Davison, Alexander Broomfield, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Pediatric Research|November 3, 2025
Co-design and evaluation of a regional and rural translation bronchiolitis platform: study protocolLouise Shaw, Catherine Wilson, Meredith Borland, et al.
Plos Genetics|April 13, 2011
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafishAdriana Rodríguez-Marí, Catherine Wilson, Tom A Titus, et al.
The Medical Journal of Australia|August 14, 2021
The characteristics of SARS-CoV-2-positive children who presented to Australian hospitals during 2020: a PREDICT network studyLaila F Ibrahim, Doris Tham, Vimuthi Chong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2022
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis reportPriya S Kishnani, David Kronn, Anaïs Brassier, et al.
Journal of Neuromuscular Diseases|October 10, 2022
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant CohortTina Duong, Priya S Kishnani, Kristina An Haack, et al.
Current Biology : CB|December 4, 2020
The Developmental and Genetic Architecture of the Sexually Selected Male Ornament of SwordtailsManfred Schartl, Susanne Kneitz, Jenny Ormanns, et al.
BMJ Open|December 23, 2025
Organ donation for research purposes: a qualitative focus group study on the views of donor families, transplant recipients and heart failure patients in the UKJohn Onsy Louca, Nicole Asemota, Johanna Thren, et al.
The Medical Journal of Australia|April 22, 2023
The characteristics of SARS-CoV-2-positive children in Australian hospitals: a PREDICT network studyLaila Ibrahim, Catherine Wilson, Doris Tham, et al.
The Journal of Pediatrics|May 31, 2025
The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase AlfaDavid Kronn, James Davison, Alexander Broomfield, et al.
Pageof 14